DCP-LA Elastin Synthesis Regeneration Anti-Aging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments lack effective agents to promote the synthesis and regeneration of elastin fibers, which are crucial for maintaining skin elasticity and preventing wrinkles, as elastin production decreases with age and is degraded by environmental factors like UV exposure.
Innovation Solution
The compound 8-[2-(2-pentyl-cyclopropylmethyl)-cyclopropyl]-octanoic acid (DCP-LA) is used as an active ingredient to promote elastin synthesis, regeneration, and fibrin-5 secretion, thereby preventing wrinkle formation and improving skin elasticity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments are used, then skin aging symptoms appear due to decreased elastin production and decomposition, but no effective agent is available to promote elastin synthesis and regeneration
Solution Approach 1:
The patent uses DCP-LA as an intermediary substance that mediates between fibroblasts and elastin production. DCP-LA acts as a signaling molecule that binds to specific receptors on fibroblast cells, triggering intracellular pathways that stimulate elastin synthesis and protect against elastin decomposition, thereby resolving the contradiction between promoting synthesis and preventing decomposition.
Solution Approach 2:
The patent changes the chemical parameter by introducing DCP-LA, a specific compound with unique molecular structure and properties. This parameter change (introducing the active ingredient DCP-LA) transforms the biological process by activating elastin synthesis pathways and inhibiting elastin degradation enzymes, thus simultaneously improving synthesis promotion while preventing decomposition.
2Duration of action of stationary object
If elastin production is decreased due to aging, then skin elasticity is lost and wrinkles form, but no medicament is known to promote regeneration
Solution Approach 1:
The patent applies DCP-LA as a preliminary action to prevent elastin degradation and stimulate synthesis before significant skin aging occurs. By administering DCP-LA in advance, the patent activates protective mechanisms that maintain elastin integrity and promote continuous synthesis, thereby preserving skin elasticity before the aging process severely impacts elastin production capacity.
Solution Approach 2:
The patent enables the skin's fibroblast cells to self-regulate elastin production through DCP-LA stimulation. The compound activates endogenous pathways that allow cells to autonomously increase elastin synthesis and enhance their own protective mechanisms against degradation, making the system self-sufficient in maintaining elasticity without requiring external structural modifications.
3Object-affected harmful factors
If elastin fiber is decomposed by UV exposure and environmental factors, then skin aging symptoms occur, but no agent is available to protect against this decomposition
Solution Approach 1:
The patent applies DCP-LA as a protective cushioning agent that prepares elastin fibers against future UV and environmental damage. The compound accumulates in skin tissues and creates a protective environment that buffers against oxidative stress and UV-induced degradation, thereby maintaining elastin fiber stability before harmful factors can cause significant decomposition.
Solution Approach 2:
The patent converts the harmful effects of UV exposure and oxidative stress into beneficial signals by using DCP-LA to activate protective cellular responses. The compound transforms stress conditions into opportunities for enhanced elastin synthesis and upregulation of protective enzymes, thereby converting potentially damaging environmental factors into mechanisms that strengthen elastin fiber stability.
Data Source
AI summary
8-[2-(2-Pentyl-cyclopropylmethyl)-cyclopropyl]-octanoic acid (DCP-LA) has an action to promote synthesis and regeneration of elastin, and is useful as an agent for the prophylaxis or improvement of wrinkles, and an anti-aging drug.